Fidson Healthcare Plc started operations on March 1, 1995, as a local distributor of pharmaceutical products. Barely a year after, the company started importing its own brand of finished medicines – introducing Ciprotab and Peflotab brand of quinolones to the market. By July 2002, Fidson set up its first local manufacturing facility and later became the first company in sub-Saharan Africa to manufacture Antiretroviral (ARVs) drugs in March 2005.

In February 2007, Fidson set up a second manufacturing facility and ceded the former manufacturing facility to an international joint venture project, which led to setting up of Ecomed Pharma Limited. In November of the same year, the company received the NIS ISO 9001:2000 certification of its Quality Management System by the Standard Organization of Nigeria (SON).

Expanding its business further, the company was listed on the floor of the Nigerian Stock Exchange, NSE to become a publicly quoted company in 2008 and completed its 3rd Factory (FPL) in the same year. About a year later, Fidson won the Financial Standard Sector Leader Award and received the NIS ISO 9001:2008 Certification in 2011.

Further positioning itself as a leading pharmaceutical manufacturer in Nigeria, Fidson completed its 4th Factory – An Ultra-Modern WHO Compliant Plant in Ota, Ogun State in 2016 and increased its capacity to manufacture more products across various therapeutic categories.